Economic Burden of HIV in a Commercially Insured Population in the United States
**Background:** With advances in antiretroviral therapy (ART), people with HIV infection are living longer. Pre-exposure prophylaxis (PrEP) to reduce HIV infection risk continues to be underutilized in high-risk individuals. Recent data on economic burden for patients with newly diagnosed HIV-1 or i...
Saved in:
Main Authors: | Cindy Y. Chen, Prina Donga, Alicia K. Campbell, Babafemi Taiwo |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2023-01-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.56928 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States
by: Bruno Emond, et al.
Published: (2022-02-01) -
Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors
by: Yen-Wen Chen, et al.
Published: (2022-01-01) -
Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
by: Monica Kobayashi, et al.
Published: (2023-11-01) -
A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
by: Patricia B. Schepman, et al.
Published: (2022-03-01) -
Economic Impacts of the Green Industry in the United States
by: Charles R. Hall, et al.
Published: (2005-07-01)